Mindmedicinelaw
Published September 7, 2026 · Updated September 8, 2026
Metabolomic Insights from Bio-K/NNDC IV Ketamine Trial in TRD - The Psychedelic Journal
The Bio-K/NNDC multicenter trial offers the most detailed metabolomic profile of IV racemic ketamine in treatment-resistant depression to date,.
Read the full story at Mindmedicinelaw
Surfaced by this Google Alert
- Ketamine
